3期头颈部黑色素瘤的淋巴结转移:转移模式与失败模式
该回顾性研究纳入2010至2019年53例临床淋巴结阳性头颈部皮肤黑色素瘤患者,比较术前CT与病理对淋巴结转移的评估。术前CT预测淋巴结病变的准确率为84.6%,颈部水平准确率为98.1%;作者认为符合辅助系统治疗条件的患者可根据术前影像行高度选择性颈淋巴结清扫,但需大规模临床试验进一步评估。
要点
- 术前CT预测淋巴结病变的准确率为84.6%,颈部水平准确率为98.1%。
- 10例(18.9%)病理发现非临床淋巴结,中位数为1个(范围1-2),其中9例(90%)位于CT检测的相同临床水平。
- 作者认为符合辅助系统治疗条件的患者可根据术前影像行高度选择性颈淋巴结清扫,但需大规模临床试验进一步评估。
核心结论
- 3期头颈部黑色素瘤伴临床阳性淋巴结转移且符合辅助系统治疗条件的患者,可能受益于根据术前影像研究进行的高度选择性颈淋巴结清扫。
- 该结论应在大规模临床试验中进一步评估。
研究设计与样本
- 回顾性综述2010至2019年所有临床阳性头颈部皮肤黑色素瘤患者。
- 临床疾病诊断为影像学可疑、活检证实的淋巴结。
- 将术前CT对淋巴结转移的评估与病理报告进行比较。
- 共纳入53例患者,其中40例(75.5%)为男性,平均年龄59岁(标准差15.52)。
主要发现
- 大多数患者(26.4%)原发部位未知。
- 最常见原发部位为面颊8例(15.1%),其次为前额(9.4%)和侧颈部(9.4%)。
- 术前CT在84.6%的病例中预测了淋巴结病变。
- 从先前描述的临床预测主要失败的原始区域是颈前上部,腮腺受累为83.3%。
- 10例患者(18.9%)病理诊断为非临床淋巴结,非临床淋巴结中位数为1个(范围1-2),其中9例(90%)位于CT检测的相同临床水平。
临床怎么用
- 作者认为,3期头颈部黑色素瘤伴临床阳性淋巴结转移且符合辅助系统治疗条件的患者,可能受益于根据术前影像研究进行的高度选择性颈淋巴结清扫。
- 作者指出该做法应在大规模临床试验中进一步评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stage 3 patients with clinically positive nodal metastasis are treated with therapeutic neck dissection and adjuvant systemic therapy. The aim of our study was to examined the predictability of pre-operative CT as a nodal drainage assessment tool. METHODS: Retrospective review of all patients with clinically positive head and neck cutaneous melanoma between 2010 and 2019. Clinical disease was diagnosed as radiological suspicious, biopsy-proven node. A pre-operative CT evaluation for nodal metastasis was compared to pathology report. RESULTS: A total of 53 patients were included. Forty patients (75.5%) were males with a mean age of 59 (SD 15.52). The majority of patients (26.4%) had an unknown primary site. The most common sites for primary were the cheek in eight patients (15.1%) followed by forehead (9.4%) and lateral neck (9.4%). Preoperative CT predicted nodal disease in 84.6% of cases. The primary region that mainly failed from the previously described clinical prediction was the upper anterior neck with 83.3% parotid involvement. A total of 10 patients (18.9%) were diagnosis with non-clinical nodes on pathology with a median non-clinical node of 1 (range 1-2). Of them, 9 (90%) were in the same clinical levels detected by CT. Pre-operative CT was associated with a neck level accuracy of 98.1%. CONCLUSION: Stage 3 head and neck melanoma with clinically positive nodal metastasis that are eligible for an adjuvant systemic treatment, may benefit from a highly selective neck dissection according to their pre-operative imaging studies. This should be further evaluated in a large-scale clinical trial. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:4292-4297, 2024.
引用
- Tzelnick S, de Almeida JR, Yao CMKL, et al. Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure. Laryngoscope. 2024. PMID: 38828642. doi:10.1002/lary.31515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。